Publications by authors named "Mario Cottone"

Claim this Profile
P
Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease.
Fabio Salvatore Macaluso, Giovanni Mazzola, Marco Ventimiglia, Patrizia Alvisi, Sara Renna, Mario Cottone

Digestion· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease.
Fabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, Anna Viola, Aldo Sitibondo, Mario Cottone

J Gastroenterol Hepatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis.
Fabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, Anna Viola, Maria Cappello, Mario Cottone

Dig Liver Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).
Serena Porcari, Anna Viola, Ambrogio Orlando, Antonino Carlo Privitera, Concetta Ferracane, Mario Cottone

Drugs Aging· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of biologics in pediatric inflammatory boweldisease: Real-life data from the Sicilian Network.
Anna Claudia Romeo, Marco Ventimiglia, Valeria Dipasquale, Ambrogio Orlando, Michele Citrano, Mario Cottone

Clin Res Hepatol Gastroenterol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of Ustekinumab for the treatment of Crohn's disease in real-life experiences: a meta-analysis of observational studies.
Fabio Salvatore Macaluso, Marcello Maida, Marco Ventimiglia, Mario Cottone, Ambrogio Orlando

Expert Opin Biol Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psoriasis and Inflammatory Bowel Disease.
Mario Cottone, Chiara Sapienza, Fabio Salvatore Macaluso, Marco Cannizzaro

Dig Dis· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and incidence of inflammatory bowel disease in two Italian islands, Sicily and Sardinia: A report based on health information systems.
Fabio Salvatore Macaluso, Giammarco Mocci, Ambrogio Orlando, Salvatore Scondotto, Giovanna Fantaci, Mario Cottone

Dig Liver Dis· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lupus-like reactions in patients with inflammatory bowel disease treated with anti-TNFs are insidious adverse events: data from a large single-center cohort.
Fabio Salvatore Macaluso, Chiara Sapienza, Marco Ventimiglia, Sara Renna, Mario Cottone

Scand J Gastroenterol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis.
Fabio Salvatore Macaluso, Marcello Maida, Marco Ventimiglia, Sara Renna, Mario Cottone

Inflamm Bowel Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities.
Fabio Salvatore Macaluso, Mario Cottone, Ambrogio Orlando

Clin Gastroenterol Hepatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn's Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease.
Fabio Salvatore Macaluso, Walter Fries, Antonio Carlo Privitera, Maria Cappello, Sebastiano Siringo, Mario Cottone

J Crohns Colitis· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-interleukin-12 and anti-interleukin-23 agents in Crohn's disease.
Fabio Salvatore Macaluso, Ambrogio Orlando, Mario Cottone

Expert Opin Biol Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter: SPOSIB SB2-a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2.
Fabio Salvatore Macaluso, Maria Cappello, Enrica Giuffrida, Walter Fries, Andrea Centritto, Mario Cottone

Aliment Pharmacol Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis.
Sara Renna, Filippo Mocciaro, Marco Ventimiglia, Rosalba Orlando, Fabio Salvatore Macaluso, Mario Cottone

Dig Liver Dis· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases.
Fabio Salvatore Macaluso, Rosalba Orlando, Walter Fries, Mariangela Scolaro, Antonio Magnano, Mario Cottone

Dig Liver Dis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How clinicians and pathologists interact concerning inflammatory bowel disease in Italy: An IG-IBD survey.
Fabio Salvatore Macaluso, Ambrogio Orlando, Gabrio Bassotti, Aroldo Gabriele Rizzo, Alessandro Armuzzi, Mario Cottone

Dig Liver Dis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study.
Fabio Salvatore Macaluso, Chiara Sapienza, Marco Ventimiglia, Sara Renna, Giulia Rizzuto, Mario Cottone

Inflamm Bowel Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Epstein-Barr virus infection associated with the pathogenesis of microscopic colitis?
Aroldo Gabriele Rizzo, Ambrogio Orlando, Elena Gallo, Andrea Bisanti, Stefania Sferrazza, Mario Cottone

J Clin Virol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease.
Ambrogio Orlando, Rosalba Orlando, Francesco Ciccia, Sara Renna, Aroldo Rizzo, Mario Cottone

Ann Rheum Dis· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience.
Fabio Salvatore Macaluso, Sara Renna, Marcello Maida, Mariangela Dimarco, Chiara Sapienza, Mario Cottone

Scand J Gastroenterol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease.
Paolo Gionchetti, Fernando Rizzello, Vito Annese, Alessandro Armuzzi, Livia Biancone, Mario Cottone

Dig Liver Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JC Virus and Lung Adenocarcinoma: Fact or Myth?
Emanuele Sinagra, Dario Raimondo, Elena Gallo, Mario Stella, Mario Cottone

Anticancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).
Livia Biancone, Vito Annese, Sandro Ardizzone, Alessandro Armuzzi, Emma Calabrese, Mario Cottone

Dig Liver Dis· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biologics of ulcerative colitis.
Fabio Salvatore Macaluso, Sara Renna, Ambrogio Orlando, Mario Cottone

Expert Opin Biol Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis